Loading
Enzyme capsules taken with every meal replace the digestive enzymes a pancreas blocked or removed by cancer no longer delivers; NICE says to offer them to everyone with unresectable pancreatic cancer and to consider them around surgery.
Pancreatic exocrine insufficiency, with fat malabsorption, steatorrhoea and weight loss, affects about 72 percent of people with advanced pancreatic cancer and is commoner with tumours of the head (relative risk 3.36) (Iglesia 2020, seven cohorts). NICE NG85 recommends enteric-coated pancreatin for people with unresectable pancreatic cancer (1.6.1) and says to consider it before and after resection (1.6.2); it notes the September 2024 supply disruption and points to the Specialist Pharmacy Service tool for equivalent products. Evidence of benefit is mixed: observational studies pooled by Iglesia and colleagues associate replacement with 3.8 months longer survival and better quality of life, but the one multicentre randomised trial (88 patients on chemotherapy for unresectable disease, 48,000 lipase units a meal) found no difference in body mass index at eight weeks (Saito 2018). Dosing is titrated to symptoms, typically 40,000 to 50,000 units of lipase with meals and half that with snacks, taken with the first mouthfuls; acid suppression is added when response is poor.
Replaces lipase, protease and amylase in the duodenum so that fat, protein and starch are digested; the enteric coating releases the enzymes at the alkaline pH of the small bowel.
1.Pancrelipase (pancreatic enzyme replacement therapy) binds its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Pancrelipase" OR ABSTRACT:"Pancrelipase" OR TITLE:"pancreatic enzyme replacement therapy" OR ABSTRACT:"pancreatic enzyme replacement therapy" OR TITLE:"Creon" OR ABSTRACT:"Creon" OR TITLE:"Nutrizym" OR ABSTRACT:"Nutrizym" OR TITLE:"Pancrease" OR ABSTRACT:"Pancrease" OR TITLE:"PERT" OR ABSTRACT:"PERT") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Pancrelipase (pancreatic enzyme replacement therapy), not a curated reading list.
Shares Palliation in pancreatic cancer: biliary and duodenal stents, coeliac plexus block, enzymes and cachexia, Cancer cachexia, Metastatic pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Metastatic pancreatic ductal adenocarcinoma.
Shares Nutrition support and cachexia management, Cancer cachexia, Locally advanced unresectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Metastatic pancreatic ductal adenocarcinoma.
Shares Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Nutrition support and cachexia management, Cancer cachexia.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Metastatic pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Metastatic pancreatic ductal adenocarcinoma.
Shares Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Nutrition support and cachexia management.